Wayne Nasby is the Chief Operating Officer of CURE Pharmaceutical. As COO, Wayne leads the executive management team to focus on the development and commercialization of innovative and technically complex pharmaceutical products. Wayne has been recognized by industry and regulatory leaders in cGMP pharmaceutical regulatory compliance and innovation. He has successfully built pharmaceutical manufacturing facilities in Asia, Europe and the United States. With more than 30 years’ experience in the biotechnology and pharmaceutical industry, Wayne has held a variety of roles within the areas of corporate quality, supply chain management, manufacturing, process development and project management. Prior to CURE, he served as Vice President of Operations at Innozen Inc. where he was responsible for commercial manufacturing locations, quality assurance and Innozen’s supply chain. Wayne also served early on in various leadership positions at AMGEN, Inc. where he was instrumental in helping build the industry’s largest Biotechnology company. During his twenty-year tenure at AMGEN, Inc. he was responsible for the distribution and transportation of bulk and commercial biotechnology products within the United States and to Asia, Australia, Europe and Puerto Rico.